NCT03772158View on ClinicalTrials.gov

Cetirizine Chewable Bioequivalence and Food Effect Study

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 11, 2018

Primary Completion Date

February 3, 2019

Study Completion Date

February 3, 2019

Conditions
Allergy
Interventions
DRUG

Cetirizine 10mg

Chewable tablet

DRUG

Cetirizine 10 mg

Immediate Release Tablet

DRUG

Cetirizine 10 mg

Immediate Release Tablet

Trial Locations (1)

H3P 3P1

Algorithme (An altascience Company), Mount Royal

All Listed Sponsors
lead

Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division

INDUSTRY

NCT03772158 - Cetirizine Chewable Bioequivalence and Food Effect Study | Biotech Hunter | Biotech Hunter